Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

8:04 AM ET 8-K
Executive Compensation Butterfly Network, Inc. BFLY

Butterfly Network Executive Compensation

Butterfly Network appointed Michael Noonen to its Board of Directors and its Compensation and Technology Committees, effective October 9, 2026. In connection with his appointment, Noonen will receive an initial grant of restricted stock units (RSUs) valued at $300,000, which will vest over three years. Noonen is a seasoned semiconductor executive who previously served as CEO of Swave Photonics and MixComm.

Counterparty
Michael Noonen
Term
until next annual meeting
8:02 AM ET Form 4
Insider Selling NXP Semiconductors N.V. NXPI

NXP Semiconductors EVP, Chief People Officer Christopher L. Jensen Sells $805K of Stock

Christopher L. Jensen, EVP, Chief People Officer, sold 3,355 shares of NXP Semiconductors N.V. at $240.00 a share, worth $805K in total on Oct 1, 2026. Shares held after the trade: 288 (-92.1%).

Value
$805K
Shares
3,355
Price
$240.00
Role
EVP, Chief People Officer
Holding change
-92.1%
Trade date
Oct 1, 2026
8:01 AM ET 8-K
Clinical Trial Data Vaxcyte, Inc. PCVX

Vaxcyte Clinical Trial Data

Vaxcyte announced positive topline results from its OPUS-1 pivotal Phase 3 trial of VAX-31, a 31-valent pneumococcal conjugate vaccine candidate for adults. The trial met all prespecified primary immunogenicity and safety endpoints, demonstrating noninferiority to Prevnar 20 and Capvaxive. These results will support a planned Biologics License Application (BLA) submission to the FDA in the first half of 2028.

Earnings call
Oct 5, 2026, 8:00 AM ET
8:01 AM ET 8-K
Investor Presentation SS Innovations International, Inc. SSII

SS Innovations International Investor Presentation

SS Innovations International, Inc. (SSII) filed an updated October 2026 Company Presentation to be used in communications with shareholders and the investment community. The presentation highlights the company's proprietary surgical robotic system, the SSi Mantra 3, and its vision for affordable surgical robotic solutions.

8:01 AM ET 8-K
Reverse Stock Split Jasper Therapeutics, Inc. JSPR

Jasper Therapeutics Reverse Stock Split

Jasper Therapeutics stockholders approved an amendment to the Certificate of Incorporation to effect a reverse stock split at a ratio between 1-for-15 and 1-for-35. Stockholders also approved increasing the total number of authorized shares of common stock from 490 million to 675 million.

8:01 AM ET 8-K
Business Update Rezolute, Inc. RZLT

Rezolute Business Update

Rezolute announced that the FDA recommended a pre-BLA meeting for ersodetug in congenital hyperinsulinism (HI) following a review of Phase 3 sunRIZE data. Although the trial missed its primary and key secondary endpoints, the Agency encouraged the meeting as a precursor to a potential Biologics License Application (BLA) submission. The company is also awaiting Phase 3 upLIFT results in tumor HI this quarter to finalize its overall regulatory strategy.

Counterparty
FDA

“We appreciate FDA’s thorough review of the extensive body of data generated in sunRIZE and are encouraged by the Agency’s recognition that this data will require in-depth evaluation during a formal BLA review.”

Nevan Charles Elam, Chief Executive Officer and Founder of Rezolute
8:00 AM ET 8-K
Other 8-K Filing Quality Industrial Corp. QIND

Quality Industrial Other 8-K Filing

Quality Industrial Corp. filed Second Amended and Restated Articles of Incorporation, which increased the authorized common stock from 450 million to 1 billion shares. The amendment also grants the Board of Directors the authority to sell or exchange substantially all of the company's assets without stockholder approval and expands liability protection to include officers. These changes were approved by Fusion Fuel Green PLC, which holds approximately 51.9% of the company's voting power.

8:00 AM ET 8-K
Capital Raise Strategy Inc MSTR

Strategy Capital Raise of $15.7M

Strategy Inc reported that between October 1 and October 4, 2026, it sold 92,894 shares of Class A Common Stock under its at-the-market (ATM) offering program for net proceeds of $15.7 million. The company utilized these proceeds, along with existing cash, to acquire 334 additional bitcoins for approximately $28.7 million, bringing its total holdings to 848,000 bitcoins.

Value
$15.7M
8:00 AM ET 8-K
Business Update Strive, Inc. ASST

Strive Business Update

Strive, Inc. provided an operational update disclosing that it purchased 2,000 bitcoin between September 28 and October 2, 2026, at an average price of $84,422 per bitcoin. As of September 30, 2026, the company held 28,000 bitcoin with a fair value of approximately $2.34 billion and total treasury value of $2.68 billion. The filing also updated the company's cash position and share counts for its Class A, Class B, and Series A Perpetual Preferred stock.

7:46 AM ET 8-K
M&A Deal Distribution Solutions Group, Inc. DSGR

Distribution Solutions Group Signs $700M M&A Deal with LKCM Headwater Investments, LLC

Distribution Solutions Group (DSG) announced a $700 million senior notes offering to fund its previously announced merger with affiliates of LKCM Headwater Investments. Under the deal, LKCM Headwater will acquire all outstanding shares of DSG it does not already own for $35.00 per share in cash, taking the company private.

Value
$700M
Counterparty
LKCM Headwater Investments, LLC
7:36 AM ET 8-K
M&A Deal Matador Resources Co MTDR

Matador Resources Signs $1.27B M&A Deal with Paloma Permian, LLC

Matador Resources Company completed its acquisition of Paloma Permian, LLC for a cash purchase price of $1.275 billion. The deal adds approximately 16,500 net acres and over 156 net drilling locations in the Delaware Basin (Eddy and Lea Counties, New Mexico). Matador paid an as-adjusted closing price of $1.255 billion and expects to integrate the assets into its existing upstream and midstream operations.

Value
$1.27B
Counterparty
Paloma Permian, LLC
7:32 AM ET 8-K
M&A Deal Harrow, Inc. HROW

Harrow Signs $30M M&A Deal with Viatris Inc.

Harrow, Inc. completed the acquisition of the dry eye disease treatment TYRVAYA from Viatris for $30 million in cash at closing. The deal includes worldwide rights except for Japan, where Viatris will pay Harrow royalties on future sales. Harrow may also pay up to $70 million in contingent milestone payments based on net sales thresholds through 2029.

Value
$30M
Counterparty
Viatris Inc.
7:23 AM ET 8-K
M&A Deal PTC Inc. PTC

PTC Signs $22.6B M&A Deal with Schneider Electric SE

PTC Inc. has entered into a definitive agreement to be acquired by Schneider Electric SE for $205 per share in an all-cash transaction. The deal values PTC's equity at approximately $22.6 billion and will result in PTC becoming a wholly owned subsidiary of Schneider Electric, creating a scaled industrial software and AI franchise.

Value
$22.6B
Counterparty
Schneider Electric SE
Earnings call
Oct 5, 2026, 9:00 AM ET

“The acquisition of PTC represents an important step forward in our ambition to lead the new era of Energy and Industrial Intelligence. Together, we are creating the industry’s most complete Software & AI powerhouse and highest-quality portfolio bridging the physical and digital worlds.”

Olivier Blum, Chief Executive Officer of Schneider Electric

“Joining Schneider Electric is an incredible opportunity to elevate the scope and impact of what we deliver for our customers globally. We gain substantial scale and resources to accelerate innovation, advance our Intelligent Product Lifecycle vision, and expand our business into more geographies and end markets to serve more customers.”

Neil Barua, President and CEO of PTC
7:21 AM ET 8-K/A
M&A Deal Processa Pharmaceuticals, Inc. PCSA

Processa Pharmaceuticals M&A Deal with Vidya Therapeutics, Inc.

Processa Pharmaceuticals filed an amendment to its 8-K to provide audited financial statements and pro forma information following its acquisition of Vidya Therapeutics. The deal adds VT7208, a CNS-penetrant BTK inhibitor, to Processa's pipeline for the treatment of autoimmune conditions like multiple sclerosis and food allergies.

Counterparty
Vidya Therapeutics, Inc.
7:20 AM ET 8-K
M&A Deal Neighborhood Intelligence, Inc. NXH

Neighborhood Intelligence M&A Deal with Fathom Holdings, Inc.

Neighborhood Intelligence and Fathom Holdings have mutually agreed to terminate their previously announced merger agreement dated June 16, 2026. Both boards concluded that current market valuations do not appropriately reflect the fair value of either company, though they intend to explore future strategic collaborations such as data sharing.

Counterparty
Fathom Holdings, Inc.
7:01 AM ET 8-K
Leadership Change Insmed Inc INSM

Insmed Leadership Change

Sara Bonstein is stepping down as Chief Financial Officer of Insmed, effective October 30, 2026, to pursue a broader leadership role. The company has initiated a search for a successor and reaffirmed its full-year 2026 revenue guidance for BRINSUPRI and ARIKAYCE.

Earnings call
Oct 29, 2026, 8:00 AM ET
7:01 AM ET 8-K
Loan & Debt Tidewater Inc TDW

Tidewater $170M Debt Financing with Banco Nacional de Desenvolvimento Econômico e Social

Tidewater Inc. amended its BNDES Construction Loans to replace legacy parent company guarantees from Wilson Sons and Remolcadores with its own corporate guarantee following its acquisition of WSUT. The amendments, effective October 1, 2026, also involved raising interest rates on the facilities to 3.21% and 3.77% respectively.

Value
$170M
Counterparty
Banco Nacional de Desenvolvimento Econômico e Social (BNDES)
7:01 AM ET 8-K
M&A Deal Advanced Drainage Systems, Inc. WMS

Advanced Drainage Systems Signs $530M M&A Deal with StormTrap Investments, L.L.C.

Advanced Drainage Systems (ADS) has entered into a definitive agreement to acquire StormTrap Investments, a leader in space-constrained stormwater solutions, for approximately $530 million. The acquisition expands ADS's addressable market in large-volume storage and is expected to be accretive to adjusted EPS in the first year. The deal will be funded through a combination of cash on hand and the company's existing credit facility.

Value
$530M
Counterparty
StormTrap Investments, L.L.C.
7:00 AM ET 8-K
Licensing Deal Alector, Inc. ALEC

Alector Licensing Deal with Genentech, Inc. Worth $100M

Alector entered into an exclusive global licensing agreement with Genentech to develop and commercialize AL050, a brain-penetrant engineered GCase enzyme replacement therapy for Parkinson’s disease. Alector will receive a $100 million upfront payment and is eligible for up to $1.17 billion in additional milestone payments plus tiered royalties on net sales. The deal extends Alector's cash runway into 2029 while allowing the company to retain ownership of its proprietary Alector Brain Carrier platform.

Value
$100M
Counterparty
Genentech, Inc.
7:00 AM ET 8-K
Investor Meeting Camping World Holdings, Inc. CWH

Camping World Holdings Investor Meeting

Camping World Holdings lowered its full-year 2026 Adjusted EBITDA guidance to below the previous range of $230 million to $270 million due to softening RV demand and margin pressure. In response, the company implemented $50 million in incremental annualized cost savings, including headcount reductions and the closure of four dealerships. The company also announced it is exploring a refinancing of its existing term loan facility to increase financial flexibility.

6:57 AM ET 8-K
Divestiture Geo Group Inc GEO

Geo Group Divestiture to United States of America for $950M

The GEO Group completed the sale of its 2,644-bed Adelanto Complex in California to the U.S. Department of Homeland Security for $950 million in gross proceeds. The company expects to receive approximately $705 million in net proceeds, which it intends to use for debt reduction and share repurchases. GEO will continue to provide support services at the facilities under an existing contract with ICE that runs through December 2034.

Value
$950M
Counterparty
United States of America (Department of Homeland Security)
6:49 AM ET 8-K
Leadership Change Entergy Texas, Inc. ETI-P

Entergy Texas Leadership Change

Entergy Texas, Inc. appointed David C. Borde as Chairman, President, and CEO, effective October 5, 2026. He succeeds Eliecer Viamontes, who resigned from these positions on the same date. Mr. Borde, who previously served as Vice President of Utility Strategy and Regulatory Initiatives at Entergy Services, will receive an annual base salary of $450,000 and is eligible for annual cash bonuses and equity-based awards.

6:45 AM ET 8-K
Leadership Change Avery Dennison Corp AVY

Avery Dennison Leadership Change

Ignacio J. Walker, Senior Vice President and Chief Legal Officer of Avery Dennison Corporation, notified the company of his decision to resign to pursue another opportunity. He is expected to remain in his current role until his departure on October 16, 2026.

6:36 AM ET 8-K
Stock Buyback News Corp NWSA

News Announces $1B Stock Buyback

News Corp provided a daily update on its $1 billion stock repurchase program as required by Australian Securities Exchange (ASX) rules. The program authorizes the company to buy back outstanding shares of both Class A and Class B common stock from time to time in the open market. The filing includes specific daily transaction notifications for Class A common stock as part of the ongoing 2025 Repurchase Program.

Value
$1B
6:33 AM ET 8-K
Loan & Debt DocGo Inc. DCGO

DocGo $102M Debt Financing with Perceptive Credit Holdings IV, LP

DocGo Inc. and its subsidiary Ambulnz entered into an Amended and Restated Credit Agreement providing for up to $102 million in term loans, including $52 million in existing debt and $50 million in new and delayed draw facilities. The financing is structured to support the company's pending acquisition of Hicuity Health, Inc., with certain tranches funding upon the merger's closing.

Value
$102M
Counterparty
Perceptive Credit Holdings IV, LP
Term
through Dec 2029
6:31 AM ET 8-K
Contract Win Quanome Technologies, Inc. QNME

Quanome Technologies Wins $101M Contract from Xpert Software Solutions Pte. Ltd.

Quanome Technologies' subsidiary XDT Infrastructure entered into a Token Factory Master Services Agreement to provide AI inference computing capacity to XPERT SOFTWARE SOLUTIONS. The 60-month contract has an aggregate committed value of approximately $100.9 million, including a $45 million prepayment to fund server procurement and infrastructure build-out.

Value
$101M
Counterparty
XPERT SOFTWARE SOLUTIONS PTE. LTD.
Term
60 months
6:31 AM ET 8-K
Leadership Change Eaton Corp plc ETN

Eaton Corp Leadership Change

Eaton Corporation plc announced that Andrea Trabacchin has been appointed Senior Vice President and Controller, serving as the company's principal accounting officer effective October 5, 2026. He succeeds Adam Wadecki, who is transitioning to a non-executive officer role as Senior Vice President, Finance, Electrical. Mr. Trabacchin will receive an annual base salary of $485,000 with a target short-term incentive of 60%.

6:29 AM ET Form 4
Insider Selling Sea Ltd SE

Sea President of Garena Feng Zhao Sells $3.8M of Stock

Feng Zhao, President of Garena, sold 40,000 shares of Sea Ltd at $94.43 to $96.04 a share (average $95.02) in 3 transactions, worth $3.8M in total on Oct 1, 2026. Shares held after the trade: 93,580 (-7.4%).

Value
$3.8M
Shares
40,000
Average price
$95.02
Role
President of Garena
Holding change
-7.4%
Trade date
Oct 1, 2026
6:29 AM ET Form 4
Insider Selling Sea Ltd SE

Sea CCO and GC Yanjun Wang Sells $188K of Stock

Yanjun Wang, CCO and GC, sold 1,974 shares of Sea Ltd at $94.38 to $95.99 a share (average $95.09) in 5 transactions, worth $188K in total between Oct 1, 2026 and Oct 2, 2026. Shares held after the trade: 87,806 (-0.3%).

Value
$188K
Shares
1,974
Average price
$95.09
Role
CCO and GC
Holding change
-0.3%
Trade date
Oct 1, 2026 to Oct 2, 2026
6:10 AM ET Form 4
Insider Buying VCI Global Ltd VCIG

VCI Global CEO and Director Voon Him Hoo Buys $313K of Stock

Voon Him Hoo, CEO and Director, bought 193,349 shares of VCI Global Ltd at $1.62 a share, worth $313K in total on Sep 30, 2026. Shares held after the trade: 341,715 (+130.3%).

Value
$313K
Shares
193,349
Price
$1.62
Role
CEO and Director
Holding change
+130.3%
Trade date
Sep 30, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.